Journal
ANNALS OF ONCOLOGY
Volume 12, Issue -, Pages S15-S19Publisher
OXFORD UNIV PRESS
DOI: 10.1093/annonc/12.suppl_3.S15
Keywords
adjuvant treatment; breast cancer; metastatic disease; quality of life; surgical treatment
Categories
Ask authors/readers for more resources
In recent years, evaluating quality of life (QoL) has become increasingly important as an additional measured outcome in cancer clinical trials, in particular in the field of breast cancer. This paper, after a general introduction to the present debate on the methodological issues involved in QoL evaluation, reviews results and open questions regarding the use of this measure in surgical, adjuvant and metastatic studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
